Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Prostate Cancer treatment details. Chemotherapy. Hormone. National Cancer Institute, Bethesda, MD, United States



Survival: 15.5 months
   
Toxicity Grade: 5
   
Treatments: Chemotherapy
Hormone
   
Drugs:
Country: United States
   
City/State/Province: Bethesda, MD
   
Hospital: National Cancer Institute
   
Journal: Link
   
Date: 9/2013

Description:
Patients:
This phase 2 study involved 23 metastatic castration-resistant prostate cancer patients who were previously treated with docetaxel-based chemotherapy. The median patient age was 65 years.

Treatment:
Patients were given chemotherapy with satraplatin and the steroid hormone prednisone.

Toxicities:
There was one treatment-related death due to septic shock. Grade 4 thrombocytopenia, neutropenia, and low blood pressure were also reported.

Results:
The median overall survival was 15.5 months.

Correspondence: Dr. William D. Figg; email: figgw@helix.nih.gov

E-mail to a Friend Email Physician More Information